Methods and devices for sequencing nucleic acids in smaller batches

1. A method for carrying out steps of a nucleic acid sequencing protocol, said method comprising:

a) providing: i) a reservoir comprising nucleic acid sequencing reagents in a fluid; ii) nucleic acids in a flow cell to be sequenced, said flow cells mounted on iii) a moveable support, said support configured to move said flow cell to iv) a reagent delivery station in fluidic communication with said reservoir;

b) moving said moveable support under conditions such that said flow cell is connected to the reagent delivery station, whereby said flow cell is in fluid communication with said reservoir;

c) introducing reagent via said reservoir into said flow cell under conditions such that said reagent contacts said nucleic acids; and

d) moving said moveable support such that said flow cell is disconnected with said reagent delivery station under conditions such that fluid does not flow back to said reservoir.

2. The method of claim 1 , wherein said nucleic acid sequencing reagents comprise dye-labeled nucleotide analogues.

3. The method of claim 2 , wherein said labeled nucleotides are introduced at step c).

4. The method of claim 3 , wherein said nucleotides are introduced at step c) in a volume that is less than 50 microliters.

5. The method of claim 4 , wherein said nucleotides are introduced at step c) in a volume of approximately 20 microliters or less.

6. The method of claim 1 , wherein said nucleic acids are on a chip in said flow cell.

7. The method of claim 1 , further comprising adding a second flow cell comprising nucleic acids to said moveable support.

8. The method of claim 7 , wherein said second flow cell was not present on said moveable support prior to step b).

9. The method of claim 7 , wherein at least a portion of said flow cells is transparent.

10. The method of claim 1 , wherein said moveable support is a carousel.

11. The method of claim 10 , wherein said carousel is under the control of a processor.

12. The method of claim 11 , wherein said processor can be programmed to change the movement of said carousel.

13. The method of claim 1 , wherein said nucleic acids are immobilized on a plurality of beads in said flow cell.

14. A system comprising i) a reservoir comprising nucleic acid sequencing reagents; ii) nucleic acids in a flow cell, said flow cell mounted on iii) a moveable support, said support configured to move said flow cell to iv) a reagent delivery station in fluidic communication with said reservoirs and v) a mechanism capable of raising said moveable support so as to disconnect said flow cell from said station.

15. The system of claim 14 , further comprising a camera for imaging said flow cell.

16. The system of claim 14 , wherein said system further comprises a programmable processor and is contained within the housing of an instrument, said instrument comprising a user interface, said user interface in communication with said programmable processor.

17. The system of claim 15 , further comprising an imaging platform capable of x/y movement, said imaging platform positioned under said camera.

18. The system of claim 17 , further comprising a transfer means capable of moving at least one of said flow cells from said moveable support to said imaging platform.

19. A method for carrying out steps of a nucleic acid sequencing protocol, said method comprising:

a) providing: i) an imaging platform capable of x/y movement; ii) a camera positioned above said imaging platform; iii) a plurality of reservoirs, at least one of which comprising nucleic acid sequencing reagents; iv) a first flow cell and a second flow cell, said first and second flow cells comprising nucleic acid templates to be sequenced, said flow cells mounted on v) a carousel, said carousel configured to move said flow cells to vi) a plurality of stations, at least some stations comprising reagent delivery stations in fluidic communication with at least one of said reservoirs; and vii) a mechanism capable of moving at least one of said flow cells from said carousel to said imaging platform, and from said imaging platform to said carousel;

b) moving said carousel under conditions such that said first flow cell is connected to the reagent delivery station, whereby said first flow cell is in fluid communication with at least a first reservoir of said plurality of reservoirs;

c) introducing reagent via one of said reservoirs into said first flow cell under conditions such that said reagent contacts said nucleic acid templates of said first flow cell; and

d) moving said carousel under conditions such that i) said first flow cell is disconnected with said reagent delivery station, and ii) said second flow cell is connected to said reagent delivery station, whereby said second flow cell is in fluid communication with at least said first reservoir of said plurality of reservoirs.

20. The method of claim 19 , wherein said first flow cell is connected in step d) to a station associated with a second step in said sequencing protocol.

21. The method of claim 20 , wherein said second step is a wash step wherein said first flow cell is contacted with wash buffer.

22. The method of claim 21 , wherein said nucleic acid sequencing reagents comprise labeled nucleotides analogues which are introduced at step c).

23. The method of claim 22 , wherein said first flow cell is transferred to said imaging platform via said transfer means.

24. The method of claim 23 , wherein said flow cell transferred to said imaging platform is scanned and imaged with said camera.

25. The method of claim 24 , wherein, after said flow cell is imaged, said first flow cell is transferred back to said carousel via said transfer means.

26. The method of claim 25 , wherein said flow cell is transferred back to the same station from which it was transferred.

27. The method of claim 25 , wherein said flow cell is transferred back to a different station.

28. The method of claim 19 , wherein said nucleic acid templates in said first flow cell are from a first human patient and said nucleic acid templates in said second flow cell are from a second human patient.

29. A method for carrying out steps of a nucleic acid sequencing protocol comprising a cycle of steps, said method comprising:

a) providing: i) a plurality of flow cells, said flow cells comprising nucleic acid templates to be sequenced in an area to be imaged, said flow cells mounted on ii) a moveable support, said support configured to move said flow cells to iii) a plurality of stations, at least some of which are reagent delivery stations, each reagent delivery station in fluidic communication with at least one reservoir of a plurality of reservoirs, some of said reservoirs comprising reagent;

b) moving said moveable support under conditions such that a first flow cell of said plurality of flow cells is connected to the reagent delivery station associated with a first step in said sequencing protocol, whereby said first flow cell is in fluid communication with at least a first reservoir of said plurality of reservoirs;

c) introducing reagent via one of said reservoirs into said first flow cell under conditions such that said reagent contacts said nucleic acid templates in said first flow cell; and

d) raising said moveable support under conditions such that said first flow cell is disconnected with said reagent delivery station associated with said first step.

30. The method of claim 29 , wherein the number of flow cells is equal to the number of steps in one cycle.

31. The method of claim 29 , wherein said nucleic acid templates are on a first chip in said first flow cell.

32. The method of claim 29 , wherein said nucleic acid templates are immobilized on a plurality of beads in said first flow cell.

33. The method of claim 29 , wherein said area to be imaged is approximately 35 mm×2.5 mm, or less.

34. The method of claim 33 , wherein said area to be imaged is not less than 10% of the area defined by 35 mm×2.5 mm.

35. The method of claim 29 , wherein said reagent of step c) comprises labeled nucleotide analogues, said analogues comprising i) a label attached to the base of said nucleotide analogues via a cleavable linker and ii) a cleavable blocking group on the sugar.